More than 80 percent of 23andMe customers agree to let the company share their DNA with research partners. Getty Images

Genetics testing company 23andMe wants users to rate their treatments for some conditions such as depression and asthma in a new feature it unveiled Thursday. The company is starting with 18 common health conditions, including allergies, Type 2 diabetes, migraines and more. Only three of them are associated with a genetic report, said Jessie Inchauspe, the product manager who led the treatment page work. Users can see what others have reported about the effectiveness of various treatments. The page also lists how many users experience the condition. About 4,500 users have shared 30,000 reviews since the company started testing the treatment pages over the past few weeks.

People can also access 23andMe's research. The company doesn't have any immediate plans for how it will use the data it gathers from people's responses, but it could eventually use it to conduct more research, Inchauspe said. 23andMe has already collected data from the initial rollout. It found 36 percent of users experience seasonal allergies and top treatments include Flonase, Zyrtec, Claritin and Allegra. "I would say in general as a company, we're really interested in helping customers with all aspects of their health," she said. "We don't have any immediate plans with the data, but you could imagine it leading to more detailed research in the future. Our mission as a company is all about giving people access to data and allowing them to use it."